Join to View Full Profile
9800 Medical Center DrSte A209Rockville, MD 20850
Phone+1 301-770-3222
Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterResidency, Family Medicine, 1975 - 1978
Weill Cornell MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1977 - Present
MD State Medical License 2002 - 2026
DC State Medical License 1986 - 2004
American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2004
- Elected Member The American Society for Clinical Investigation, 1990
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- Assessment of Health Status and Creation of a Registry of Potential Research Participants Aged 1.5 to 50 Years on Bioko Island, Equatorial Guinea.María Silvia Angué López Mikue, Said Abdallah Jongo, Vicente Urbano Nsue Ndong Nchama, Ali Hamad Said, Ali Mtoro
The American Journal of Tropical Medicine and Hygiene. 2025-03-25 - Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection.Andrea A Berry, Thomas L Richie, L W Preston Church, Matthew B Laurens, Colleen Boyce
Malaria Journal. 2025-03-17 - Protective targets of PfSPZ vaccines identified from whole-genome sieve analysis of isolates from malaria vaccine efficacy trials in West Africa.Ankit Dwivedi, Ryan J Scalsky, David G Harris, Thomas C Stabler, Biraj Shrestha
Medrxiv. 2025-03-06
Journal Articles
- Oa Ruth Nussenzweig (1928–2018) Malaria Vaccine and Immunology PioneerStephen Hoffman, MD, The American Journal of Tropical Medicine and Hygiene
Press Mentions
First-of-Its-Kind Vaccine Expands Malaria Protection for Pregnant WomenAugust 14th, 2024- New Genomic Research Shows Why Testing Malaria Vaccines in the Clinic Is as Rigorous as Natural Exposure in the FieldJuly 18th, 2022
- Sanaria Vaccine Results Show Unprecedented Progress in Battle Against Variant MalariaJune 30th, 2021
- Join now to see all
Grant Support
- Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoitesSANARIA, INC.2016–2027
- Progressing PfSPZ vaccines for malaria to licensure and commercializationSANARIA, INC.2023–2026
- Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccinesSANARIA, INC.2021–2026
- Modularizing manufacture of PfSPZ vaccines: ookinete production for PfSPZ manufacture in mosquitoes and in vitroSANARIA, INC.2023–2025
- Automating mosquito microdissection for a malaria PfSPZ vaccineSANARIA, INC.2017–2025
- A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccineSANARIA, INC.2016–2025
- In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria VaccineSANARIA, INC.2010–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
